SABR vs. Limited Resection for Non-small Cell Lung Cancer: Are We Closer to an Answer? - Wikidata - wikimedia - TriplyDB

SABR vs. Limited Resection for Non-small Cell Lung Cancer: Are We Closer to an Answer?

SABR vs. Limited Resection for Non-small Cell Lung Cancer: Are We Closer to an Answer?

http://www.wikidata.org/entity/Q38813253

about

Pros: After stereotactic ablative radiotherapy for a peripheral early-stage non-small cell lung cancer, radiological suspicion of a local recurrence can be sufficient indication to proceed to salvage therapy Shared decision making in the treatment of stage I non small cell lung cancer-a choice which should equally involve both sides

P2860

Q42330755-890FF391-5EF4-4301-8C22-31C2E9DBB4E6 Q42359042-002C18C1-A040-4ABC-AFD8-A08843FAE27B

P2860

SABR vs. Limited Resection for Non-small Cell Lung Cancer: Are We Closer to an Answer?

http://www.wikidata.org/entity/Q38813253

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

SABR vs. Limited Resection for Non-small Cell Lung Cancer: Are We Closer to an Answer?

@en

type

label

SABR vs. Limited Resection for Non-small Cell Lung Cancer: Are We Closer to an Answer?

@en

prefLabel

SABR vs. Limited Resection for Non-small Cell Lung Cancer: Are We Closer to an Answer?

@en

P1433

Q38813253-648B58D8-D97C-451E-B181-3827AFD7C6CC

P1476

Q38813253-D9B1180E-EE18-42B2-B418-47F9267D7C8A

P2093

Q38813253-4C81DD4D-3137-45D8-A00A-15EE2B734DC5

Q38813253-506054F0-155F-4143-B105-6DED6F00C302

P2860

Q38813253-01A2BA3C-C240-4D7D-8569-18FFF264C916

Q38813253-0C997C46-3430-4C4B-BF61-3FA31537741C

Q38813253-0EDB1D96-6762-4963-8431-61B073FC43DD

Q38813253-16650C1A-AE3F-4C38-891C-381DB3EB7DF2

Q38813253-1C0E46EF-F69F-4CAA-8D24-539234953117

Q38813253-234F2B3D-E807-44F4-BE15-3812262AC6AD

Q38813253-2A94A3A8-C389-488C-B46F-B434282CCB29

Q38813253-2C021067-4EBC-41AC-B223-CE924A253706

Q38813253-2F4FFFC2-E2B2-4EE5-AADC-F752A2A78768

Q38813253-30B0EA5A-A73F-4B89-9F4A-A9AC4C130F55

P2888

Q38813253-E5B1D67A-866F-43F4-A7F4-93954B11797D

P304

Q38813253-B5B03296-858A-43AE-97F4-8C903F36DA89

P31

Q38813253-BB91D534-9F13-49B0-9B18-549689A1F362

P356

Q38813253-F0178258-DD64-4C51-B348-AB15E35731C2

P433

Q38813253-B24CA9BF-D8F7-4591-84DC-ED2AD2945C3B

P478

Q38813253-8A0A9F2B-49AC-4B0D-8E1C-E9E1F3EB6A69

P577

Q38813253-78CD9650-5A75-4B0C-8F02-1F3AC71A695F

P5875

Q38813253-28D7EAE3-01F3-4DA0-B830-BC9FA8C9C156

P6179

Q38813253-A0E5B7D2-338D-476A-8622-B6526760A3C3

P698

Q38813253-4EB269D9-45E2-49C3-BC61-43668D015859

P356

S11864-016-0407-3

P1433

Current Treatment Options in Oncology

P1476

SABR vs. Limited Resection for Non-small Cell Lung Cancer: Are We Closer to an Answer?

@en

P2093

Alexander V Louie

http://www.w3.org/2001/XMLSchema#string

Hanbo Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Outcomes of stereotactic ablative radiotherapy for central lung tumours: a systematic review

Cost-effectiveness of stereotactic radiation, sublobar resection, and lobectomy for early non-small cell lung cancers in older adults

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012

Analysis of longitudinal quality-of-life data in high-risk operable patients with lung cancer: results from the ACOSOG Z4032 (Alliance) multicenter randomized trial

Impact of brachytherapy on local recurrence rates after sublobar resection: results from ACOSOG Z4032 (Alliance), a phase III randomized trial for high-risk operable non-small-cell lung cancer

Thirty- and ninety-day outcomes after sublobar resection with and without brachytherapy for non-small cell lung cancer: results from a multicenter phase III study.

Lobectomy, sublobar resection, and stereotactic ablative radiotherapy for early-stage non-small cell lung cancers in the elderly.

Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials.

Survival After Sublobar Resection versus Lobectomy for Clinical Stage IA Lung Cancer: An Analysis from the National Cancer Data Base.

What do we mean by partnership in making decisions about treatment?

P2888

s11864-016-0407-3

P304

27

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11864-016-0407-3

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P577

2016-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

301568199

http://www.w3.org/2001/XMLSchema#string

P6179

1005083493

http://www.w3.org/2001/XMLSchema#string

P698

27098533

http://www.w3.org/2001/XMLSchema#string